PB
BIO icon

Pinnacle Bancorp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Pinnacle Bancorp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94K Sell
10
-4
-29% -$1.14K ﹤0.01% 879
2026
Q1 		$3.9K Hold
14
– – ﹤0.01% 825
2025
Q4 		$4.24K Hold
14
– – ﹤0.01% 806
2025
Q3 		$3.92K Sell
14
-6
-30% -$1.63K ﹤0.01% 830
2025
Q2 		$4.83K Hold
20
– – ﹤0.01% 800
2025
Q1 		$4.87K Hold
20
– – ﹤0.01% 785
2024
Q4 		$6.57K Hold
20
– – ﹤0.01% 753
2024
Q3 		$6.69K Hold
20
– – ﹤0.01% 747
2024
Q2 		$5.46K Sell
20
-20
-50% -$5.82K ﹤0.01% 745
2024
Q1 		$13.8K Hold
40
– – ﹤0.01% 611
2023
Q4 		$12.9K Buy
40
+3
+8% +$940 ﹤0.01% 595
2023
Q3 		$13.3K Hold
37
– – ﹤0.01% 574
2023
Q2 		$14K Buy
37
+9
+32% +$3.66K ﹤0.01% 551
2023
Q1 		$13.4K Buy
28
+20
+250% +$9.36K ﹤0.01% 560
2022
Q4 		$3K Buy
+8
New +$3.23K ﹤0.01% 688

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Pinnacle Bancorp's BIO Position: Q2 2026 in Review

Pinnacle Bancorp reduced its Bio-Rad Laboratories Class A (BIO) stake by 29% in Q2 2026, selling an estimated $1.14K and leaving 10 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Pinnacle Bancorp first reported a position in BIO in Q4 2022 and has held it in 15 quarters since. The position peaked at $14K in Q2 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Pinnacle Bancorp held 10 shares of Bio-Rad Laboratories Class A worth $2.94K as of Q2 2026.
  • Pinnacle Bancorp sold 4 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.14K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #879 holding.
  • Pinnacle Bancorp first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and has held it in 15 quarters since.
  • Pinnacle Bancorp's Bio-Rad Laboratories Class A position peaked at $14K in Q2 2023.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.